Modified percutaneous vertebral body-intervertebral disc biopsy combined with genetic testing for the diagnosis of early-stage pyogenic spondylodiscitis: a retrospective cohort study.

Authors

Yiquan Ji, Yefeng Yu, Tian Gao, Zehua Xu, Zhewei Ma, Haiyang Yang, Huigen Lu, Bao Chen, Xuekang Pan

Published in

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

This study aims to assess the diagnostic efficacy of a novel integrated approach that combines a modified percutaneous disc biopsy technique with 16 S rRNA gene sequencing to enhance pathogen identification in patients with early suspected pyogenic spondylodiscitis (PS).
A retrospective cohort study was conducted, enrolling 66 patients who underwent percutaneous biopsy based on clinical and MRI findings indicative of early PS between January 2021 and January 2024. Patients were categorized into two groups: Group A (n = 31), which received traditional transpedicular biopsy coupled with 16 S rRNA gene sequencing, and Group B (n = 35), which received the modified transpedicular-vertebral-discal biopsy combined with genetic testing. A composite follow-up, including clinical symptoms, imaging, and laboratory findings at ≥ 6 months, served as the gold standard. Pathogen detection rates, complication rates, and pathogen profiles were compared between the groups.
Baseline characteristics were comparable between the groups. The pathogen detection rate in Group B (85.7%, 30/35) was significantly higher than that in Group A (51.6%, 16/31), with a statistically significant difference (P < 0.01). No serious procedure-related complications were observed in either group. The predominant infection in both groups was monomicrobial bacterial infection, with Staphylococcus aureus identified as the most common pathogen.
The modified percutaneous biopsy technique combined with 16 S rRNA gene sequencing significantly improves pathogen detection in early pyogenic spondylodiscitis without increasing the risk of complications. This integrated approach demonstrates substantial diagnostic value and shows promise as a first-line minimally invasive diagnostic method.

PMID:
42363976
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.